Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).
Publication
, Journal Article
McEvoy, JW; Ibrahim, K; Kickler, TS; Clarke, WA; Hasan, RK; Czarny, MJ; Keramati, AR; Goli, RR; Gratton, TP; Brinker, JA; Chacko, M; Trost, JC ...
Published in: Circulation
January 16, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 16, 2018
Volume
137
Issue
3
Start / End Page
307 / 309
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Ticagrelor
- Risk Assessment
- Receptors, Purinergic P2Y12
- Purinergic P2Y Receptor Antagonists
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Percutaneous Coronary Intervention
Citation
APA
Chicago
ICMJE
MLA
NLM
McEvoy, J. W., Ibrahim, K., Kickler, T. S., Clarke, W. A., Hasan, R. K., Czarny, M. J., … Schulman, S. P. (2018). Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation, 137(3), 307–309. https://doi.org/10.1161/CIRCULATIONAHA.117.031678
McEvoy, John W., Khalil Ibrahim, Thomas S. Kickler, William A. Clarke, Rani K. Hasan, Matthew J. Czarny, Ali R. Keramati, et al. “Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).” Circulation 137, no. 3 (January 16, 2018): 307–9. https://doi.org/10.1161/CIRCULATIONAHA.117.031678.
McEvoy JW, Ibrahim K, Kickler TS, Clarke WA, Hasan RK, Czarny MJ, et al. Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation. 2018 Jan 16;137(3):307–9.
McEvoy, John W., et al. “Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).” Circulation, vol. 137, no. 3, Jan. 2018, pp. 307–09. Pubmed, doi:10.1161/CIRCULATIONAHA.117.031678.
McEvoy JW, Ibrahim K, Kickler TS, Clarke WA, Hasan RK, Czarny MJ, Keramati AR, Goli RR, Gratton TP, Brinker JA, Chacko M, Hwang C-W, Johnston PV, Miller JM, Trost JC, Herzog WR, Blumenthal RS, Thiemann DR, Resar JR, Schulman SP. Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation. 2018 Jan 16;137(3):307–309.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 16, 2018
Volume
137
Issue
3
Start / End Page
307 / 309
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Ticagrelor
- Risk Assessment
- Receptors, Purinergic P2Y12
- Purinergic P2Y Receptor Antagonists
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Percutaneous Coronary Intervention